vs
Side-by-side financial comparison of Nakamoto Inc. (NAKA) and Vir Biotechnology, Inc. (VIR). Click either name above to swap in a different company.
Nakamoto Inc. is the larger business by last-quarter revenue ($444.9K vs $240.0K, roughly 1.9× Vir Biotechnology, Inc.). Nakamoto Inc. runs the higher net margin — 8374.2% vs -67975.4%, a 76349.6% gap on every dollar of revenue. On growth, Nakamoto Inc. posted the faster year-over-year revenue change (-26.3% vs -89.9%). Over the past eight quarters, Nakamoto Inc.'s revenue compounded faster (-26.7% CAGR vs -88.0%).
Vir Biotechnology, Inc. is a clinical-stage immunology company focused on developing innovative therapies and vaccines to address serious infectious diseases including COVID-19, hepatitis B, HIV, and influenza. It operates primarily in the global biopharmaceutical market, collaborating with leading industry partners to advance its pipeline of targeted immune-based solutions for patient populations worldwide.
NAKA vs VIR — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $444.9K | $240.0K |
| Net Profit | $37.3M | $-163.1M |
| Gross Margin | — | — |
| Operating Margin | -41198.2% | -72267.9% |
| Net Margin | 8374.2% | -67975.4% |
| Revenue YoY | -26.3% | -89.9% |
| Net Profit YoY | 3820.2% | 23.7% |
| EPS (diluted) | $0.68 | $-1.17 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $444.9K | — | ||
| Q3 25 | $388.2K | $240.0K | ||
| Q2 25 | $408.5K | $1.2M | ||
| Q1 25 | $579.7K | $3.0M | ||
| Q4 24 | $603.9K | $12.4M | ||
| Q3 24 | $647.9K | $2.4M | ||
| Q2 24 | $639.1K | $3.1M | ||
| Q1 24 | $829.0K | $56.4M |
| Q4 25 | $37.3M | — | ||
| Q3 25 | $-86.0M | $-163.1M | ||
| Q2 25 | $-2.4M | $-111.0M | ||
| Q1 25 | $-1.0M | $-121.0M | ||
| Q4 24 | $-1.0M | — | ||
| Q3 24 | $-1.0M | $-213.7M | ||
| Q2 24 | $-1.3M | $-138.4M | ||
| Q1 24 | $-282.3K | $-65.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 99.1% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 97.9% | ||
| Q2 24 | — | 98.3% | ||
| Q1 24 | — | 99.9% |
| Q4 25 | -41198.2% | — | ||
| Q3 25 | -2680.4% | -72267.9% | ||
| Q2 25 | -585.4% | -9754.3% | ||
| Q1 25 | -179.7% | -4602.5% | ||
| Q4 24 | -169.3% | — | ||
| Q3 24 | -162.0% | -9718.7% | ||
| Q2 24 | -162.3% | -5158.7% | ||
| Q1 24 | -28.6% | -142.0% |
| Q4 25 | 8374.2% | — | ||
| Q3 25 | -22162.2% | -67975.4% | ||
| Q2 25 | -590.9% | -9139.9% | ||
| Q1 25 | -179.1% | -3989.6% | ||
| Q4 24 | -165.8% | — | ||
| Q3 24 | -156.5% | -8979.7% | ||
| Q2 24 | -206.5% | -4500.1% | ||
| Q1 24 | -34.1% | -115.8% |
| Q4 25 | $0.68 | — | ||
| Q3 25 | $-0.42 | $-1.17 | ||
| Q2 25 | $-0.35 | $-0.80 | ||
| Q1 25 | $-0.17 | $-0.88 | ||
| Q4 24 | $-0.18 | — | ||
| Q3 24 | $-0.17 | $-1.56 | ||
| Q2 24 | $-0.26 | $-1.02 | ||
| Q1 24 | $-0.06 | $-0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.6M | $497.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $514.3M | $796.1M |
| Total Assets | $730.6M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.6M | — | ||
| Q3 25 | $24.2M | $497.8M | ||
| Q2 25 | $6.0M | $598.7M | ||
| Q1 25 | $1.1M | $790.9M | ||
| Q4 24 | $2.3M | $901.0M | ||
| Q3 24 | $3.6M | $909.0M | ||
| Q2 24 | $4.7M | $1.1B | ||
| Q1 24 | $287.4K | $1.1B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $64.4K | — | ||
| Q4 24 | $148.8K | — | ||
| Q3 24 | $205.6K | — | ||
| Q2 24 | $254.7K | — | ||
| Q1 24 | $710.0K | — |
| Q4 25 | $514.3M | — | ||
| Q3 25 | $477.6M | $796.1M | ||
| Q2 25 | $9.0M | $947.5M | ||
| Q1 25 | $1.5M | $1.0B | ||
| Q4 24 | $2.6M | $1.2B | ||
| Q3 24 | $3.5M | $1.2B | ||
| Q2 24 | $4.4M | $1.4B | ||
| Q1 24 | $-383.1K | $1.5B |
| Q4 25 | $730.6M | — | ||
| Q3 25 | $692.4M | $1.0B | ||
| Q2 25 | $9.9M | $1.2B | ||
| Q1 25 | $2.6M | $1.3B | ||
| Q4 24 | $3.7M | $1.4B | ||
| Q3 24 | $4.3M | $1.5B | ||
| Q2 24 | $5.5M | $1.7B | ||
| Q1 24 | $799.3K | $1.8B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.06× | — | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.06× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-23.5M | $-167.6M |
| Free Cash FlowOCF − Capex | — | $-167.9M |
| FCF MarginFCF / Revenue | — | -69952.9% |
| Capex IntensityCapex / Revenue | — | 132.1% |
| Cash ConversionOCF / Net Profit | -0.63× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-824.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-23.5M | — | ||
| Q3 25 | $-13.2M | $-167.6M | ||
| Q2 25 | $-1.9M | $-120.2M | ||
| Q1 25 | $-865.1K | $-78.1M | ||
| Q4 24 | $-3.1M | $-446.4M | ||
| Q3 24 | $-1.0M | $-171.5M | ||
| Q2 24 | $-913.5K | $-77.8M | ||
| Q1 24 | $-213.4K | $-109.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-167.9M | ||
| Q2 25 | — | $-122.8M | ||
| Q1 25 | — | $-79.7M | ||
| Q4 24 | $-3.1M | $-453.7M | ||
| Q3 24 | $-1.0M | $-174.2M | ||
| Q2 24 | — | $-78.5M | ||
| Q1 24 | $-224.6K | $-111.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | -69952.9% | ||
| Q2 25 | — | -10111.8% | ||
| Q1 25 | — | -2630.1% | ||
| Q4 24 | -511.2% | -3666.2% | ||
| Q3 24 | -161.7% | -7321.3% | ||
| Q2 24 | — | -2553.3% | ||
| Q1 24 | -27.1% | -197.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 132.1% | ||
| Q2 25 | — | 209.1% | ||
| Q1 25 | — | 53.7% | ||
| Q4 24 | 2.2% | 59.0% | ||
| Q3 24 | 0.3% | 116.3% | ||
| Q2 24 | 0.0% | 21.7% | ||
| Q1 24 | 1.3% | 3.3% |
| Q4 25 | -0.63× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
